Bharat Technology successfully concluded the National Conference, BT-PHARMACON 2026, organized under the central theme “Pharmaceutical Innovation for Atmanirbhar Bharat: Indigenous Technologies, Affordable Healthcare and Translational Research.” Held at the Eastern Zonal Cultural Centre (EZCC), the two-day summit convened leading regulatory authorities, academic luminaries, research scientists, and over 1,000 pharmacy students and young professionals from across India.
The conference was sponsored by the Anusandhan National Research Foundation (ANRF) and Pharmacy Council of India (PCI) collaboration with Indian Pharmaceutical Association (IPA), the conclave served as a collaborative platform bridging pharmaceutical academia with industrial manufacturing needs. The inaugural assembly featured prominent regulatory leadership, including Dr. Montu M. Patel, President of the Pharmacy Council of India (PCI), alongside Chairman Prof. Deependra Singh and PCI Executive Member Shri Dharmendra Singh. Shri Amiya Kisu Minister of State (Department of FPI &H and Agriculture) also marked his presence in the conference. The dignitaries emphasized the strategic imperative of establishing national self-reliance across critical pharmaceutical fields ranging from indigenous active pharmaceutical ingredient (API) synthesis to novel drug delivery systems, nanobiotechnology, and affordable biosimilars.
In his keynote address, Dr. Montu M. Patel outlined the expanding mandate of the pharmacy profession under the national Atmanirbhar Bharat vision, urging institutions to modernize curricula, adopt global cGMP standards, and support industry-ready translational research capable of curbing critical import dependencies. Chairman Mr. Deependra Singh and Shri Dharmendra Singh commended the massive student turnout, emphasizing that India’s transition from a volume-based generic provider to a value-driven innovation powerhouse depends on cultivating indigenous research capabilities, regulatory proficiency, and patent literacy among emerging pharmacists.
The multi-session program incorporated oral and poster presentations, plenary addresses, and specialized panel tracks on artificial intelligence in drug design, green pharmacy, and UN Sustainable Development Goals (SDG 3 and SDG 9). Outstanding research scholars and innovators were recognized with merit awards for translational scientific work directly supporting domestic healthcare self-sufficiency.
Prof. (Dr.) Biplab Debnath, Principal of Bharat Technology, highlighted that the conference was envisioned around the spirit of “Atmanirbhar Bharat” and the vision of a self-reliant India.
He said the conference provided a platform for more than 1,000 participants to come together, exchange knowledge, share ideas and strengthen collaboration between academia and the pharmaceutical industry.
